Galectin Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell GALT and other ETFs, options, and stocks.

About GALT

Galectin Therapeutics, Inc. is a biotechnology company, which engages in drug research and development to create new therapies for fibrotic disease, severe skin disease, and cancer. Its programs target the development of carbohydrate molecules which offers alternative options to larger market segments. 

CEO
Joel Lewis
CEOJoel Lewis
Employees
15
Employees15
Headquarters
Norcross, Georgia
HeadquartersNorcross, Georgia
Founded
2000
Founded2000
Employees
15
Employees15

GALT Key Statistics

Market cap
189.57M
Market cap189.57M
Price-Earnings ratio
-4.96
Price-Earnings ratio-4.96
Dividend yield
Dividend yield
Average volume
326.95K
Average volume326.95K
High today
High today
Low today
Low today
Open price
$3.07
Open price$3.07
Volume
0.00
Volume0.00
52 Week high
$7.13
52 Week high$7.13
52 Week low
$1.12
52 Week low$1.12

Stock Snapshot

As of today, Galectin Therapeutics(GALT) shares are valued at $2.93. The company's market cap stands at 189.57M, with a P/E ratio of -4.96.

On 2026-01-30, Galectin Therapeutics(GALT) stock opened at $3.07, reached a high of —, and a low of —.

Galectin Therapeutics(GALT) shares are trading with a volume of 0, against a daily average of 326.95K.

During the past year, Galectin Therapeutics(GALT) stock moved between $1.12 at its lowest and $7.13 at its peak.

During the past year, Galectin Therapeutics(GALT) stock moved between $1.12 at its lowest and $7.13 at its peak.

GALT News

Simply Wall St 2h
Galectin Therapeutics Inc.'s market cap dropped US$39m last week; Individual investors bore the brunt

Advertisement Key Insights The considerable ownership by individual investors in Galectin Therapeutics indicates that they collectively have a greater say in...

Galectin Therapeutics Inc.'s market cap dropped US$39m last week; Individual investors bore the brunt

People also own

Based on the portfolios of people who own GALT. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.